TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 15,200 | 22,868 | 10,863 |
Financial expenses | 0 | 4 | 2 |
Earnings before taxes | 1,685 | 5,068 | 549 |
EBITDA | 1,620 | 5,095 | 591 |
Total assets | 3,348 | 6,491 | 3,037 |
Current assets | 3,052 | 6,220 | 2,747 |
Current liabilities | 1,866 | 2,428 | 2,595 |
Equity capital | 1,394 | 4,063 | 442 |
- share capital | 9 | 10 | 10 |
Employees (average) | 65 | 80 | 49 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 41.6% | 62.6% | 14.6% |
Turnover per employee | 234 | 286 | 222 |
Profit as a percentage of turnover | 11.1% | 22.2% | 5.1% |
Return on assets (ROA) | 50.3% | 78.1% | 18.1% |
Current ratio | 163.6% | 256.2% | 105.9% |
Return on equity (ROE) | 120.9% | 124.7% | 124.2% |
Change turnover | -5,815 | 12,206 | -2,084 |
Change turnover % | -28% | 114% | -16% |
Chg. No. of employees | -15 | 31 | 2 |
Chg. No. of employees % | -19% | 63% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.